Senestech (NASDAQ:SNES – Get Free Report) and IM Cannabis (NASDAQ:IMCC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership and risk.
Profitability
This table compares Senestech and IM Cannabis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Senestech | -304.22% | -67.60% | -49.21% |
| IM Cannabis | -27.65% | -585.96% | -39.96% |
Volatility and Risk
Senestech has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Senestech | 1 | 1 | 0 | 1 | 2.33 |
| IM Cannabis | 1 | 0 | 0 | 0 | 1.00 |
Institutional & Insider Ownership
5.2% of Senestech shares are held by institutional investors. Comparatively, 7.7% of IM Cannabis shares are held by institutional investors. 2.2% of Senestech shares are held by company insiders. Comparatively, 5.9% of IM Cannabis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation & Earnings
This table compares Senestech and IM Cannabis”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Senestech | $2.23 million | 4.08 | -$6.38 million | ($1.89) | -0.91 |
| IM Cannabis | $39.17 million | 0.04 | -$8.10 million | ($1.75) | -0.13 |
Senestech has higher earnings, but lower revenue than IM Cannabis. Senestech is trading at a lower price-to-earnings ratio than IM Cannabis, indicating that it is currently the more affordable of the two stocks.
Summary
IM Cannabis beats Senestech on 8 of the 13 factors compared between the two stocks.
About Senestech
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
About IM Cannabis
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
